Literature DB >> 3418697

Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix.

H J Dyson1, M Rance, R A Houghten, P E Wright, R A Lerner.   

Abstract

1H nuclear magnetic resonance experiments indicate formation of secondary structures in water solutions of a synthetic immunogenic peptide of sequence EVVPHKKMHKDFLEKIGGL corresponding to the C-helix (residues 69 to 87) of myohemerythrin. The conformational ensemble consists of a set of turn-like structures, distributed over the C-terminal half of the peptide and rapidly interconverting by way of unfolded states. These structures, termed nascent helix, are stabilized into helical structure with long-range order in water/trifluorethanol mixtures. Circular dichroism measurements confirm the presence of 50% helix in water/trifluoroethanol but show no evidence of helicity in water solutions of the peptide. It is apparent that no one member of the transient set of helical conformations which constitutes the nascent helix is sufficiently long to be detectable by circular dichroism experiments. No preferred conformations could be detected by nuclear magnetic resonance in the N-terminal half of the peptide, either in water or water/trifluoroethanol mixtures. This region of the peptide is stabilized in helix by long-range interactions in the folded protein. The possible role of nascent secondary structure in induction of antipeptide antibodies and in initiation of protein folding is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418697     DOI: 10.1016/0022-2836(88)90447-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  71 in total

1.  Conformational ensembles: the role of neuropeptide structures in receptor binding.

Authors:  A S Edison; E Espinoza; C Zachariah
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities.

Authors:  K H Mayo; J Haseman; H C Young; J W Mayo
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

3.  pH-induced folding of an apoptotic coiled coil.

Authors:  K Dutta; A Alexandrov; H Huang; S M Pascal
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

4.  Ultrafast folding of alpha3D: a de novo designed three-helix bundle protein.

Authors:  Yongjin Zhu; Darwin O V Alonso; Kosuke Maki; Cheng-Yen Huang; Steven J Lahr; Valerie Daggett; Heinrich Roder; William F DeGrado; Feng Gai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

5.  Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells.

Authors:  J K Larson; L Otvos; H C Ertl
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Conformation of concanavalin A and its fragments in aqueous solution and organic solvent-water mixtures.

Authors:  J M Wang; A Takeda; J T Yang; C S Wu
Journal:  J Protein Chem       Date:  1992-04

7.  Force-momentum-based self-guided Langevin dynamics: a rapid sampling method that approaches the canonical ensemble.

Authors:  Xiongwu Wu; Bernard R Brooks
Journal:  J Chem Phys       Date:  2011-11-28       Impact factor: 3.488

8.  Synthesis, folding, and structure of the beta-turn mimic modified B1 domain of streptococcal protein G.

Authors:  B Odaert; F Jean; C Boutillon; E Buisine; O Melnyk; A Tartar; G Lippens
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

9.  Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor.

Authors:  K Dahlman-Wright; H Baumann; I J McEwan; T Almlöf; A P Wright; J A Gustafsson; T Härd
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Hydration of the partially folded peptide RN-24 studied by multidimensional NMR.

Authors:  R Brüschweiler; D Morikis; P E Wright
Journal:  J Biomol NMR       Date:  1995-06       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.